Hiroyuki Tsuchiya

发表

DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts

Katsuhiro Hayashi, N. Yamamoto, M. Bouvet, 2024, AntiCancer Research.

Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases.

Katsuhiro Hayashi, N. Yamamoto, T. Higuchi, 2024, Lung cancer.